Date: 2013-01-02
Type of information: Pipeline acquisition
Acquired company: Quotient Bioresearch's Bioanalytical Sciences division (UK)
Acquiring company: LGC Standards (UK)
Amount: undisclosed
Terms: LGC and Quotient Bioresearch have reached agreement on the sale by Quotient of its Bioanalytical Sciences division to LGC. Under the terms of the transaction, Quotient and LGC have committed to collaborate as preferred partners on the provision of Bioanalytical Sciences. This will enable clients to continue to benefit from the early development services offered by the Quotient group including clinical trials, metabolism and radiolabelling. The Bioanalytical Sciences business will continue to trade using the “Quotient” name under its new ownership for the time being.
Details: Quotient Bioanalytical Sciences is a leading provider of bioanalytical services across the fields of small molecules, biomarkers, biopharmaceuticals and microbiological testing to customers in the pharmaceutical and biotechnology sectors. The acquisition, which will form part of LGC’s Health Sciences division, will enable LGC to provide an enhanced range of products and services to the pharmaceutical sector including bioanalysis, materials science and reference materials amongst others.
Related: Bioanalytical services
